| AARTIDRUGS | | | 449.25 5.50 1.21% |
Insider
Harshit Savla is Joint Director of Aarti Drugs Limited
| Age | 62 |
| Address | Mahendra Industrial Estate, Mumbai, India, 400 022 |
| Phone | 91 22 2401 9025 |
| Web | https://www.aartidrugs.co.in |
Aarti Drugs Management Efficiency
The company has return on total asset
(ROA) of
0.0617 % which means that it generated a profit of $0.0617 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity
(ROE) of
0.1224 %, meaning that it generated $0.1224 on every $100 dollars invested by stockholders. Aarti Drugs' management efficiency ratios could be used to measure how well Aarti Drugs manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Aarti Drugs'
Non Currrent Assets Other are relatively stable compared to the past year. As of 11/25/2024,
Intangible Assets is likely to grow to about 386.7
M, while
Non Current Assets Total are likely to drop slightly above 5.7
B.
Aarti Drugs Limited (AARTIDRUGS) is traded on National Stock Exchange of India in India and employs 1,064 people. Aarti Drugs is listed under Pharmaceuticals category by Fama And French industry classification.
Management Performance
Aarti Drugs Limited Leadership Team
Elected by the shareholders, the Aarti Drugs' board of directors comprises two types of representatives: Aarti Drugs inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Aarti. The board's role is to monitor Aarti Drugs' management team and ensure that shareholders' interests are well served. Aarti Drugs' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Aarti Drugs' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Harshit Savla, Joint Director | |
| Rushikesh Deole, Company Officer | |
| Prakash Patil, MD, Chairman | |
| Dhanaji Kakade, Vice Technical | |
| Vishwa Savla, Director Sciences | |
| Adhish Patil, CFO Director | |
| Rashesh Gogri, MD Director | |
| Harit Shah, WholeTime Director | |
| Uday Patil, WholeTime Director | |
Aarti Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Aarti Drugs a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Additional Tools for Aarti Stock Analysis
When running Aarti Drugs' price analysis, check to
measure Aarti Drugs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aarti Drugs is operating at the current time. Most of Aarti Drugs' value examination focuses on studying past and present price action to
predict the probability of Aarti Drugs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aarti Drugs' price. Additionally, you may evaluate how the addition of Aarti Drugs to your portfolios can decrease your overall portfolio volatility.